Fresenius Medical Care AG & Co. KGaA (FMCQF)
R&D to Revenue
0.80%
Fiscal year · Period ending:

FMCQF R&D to Revenue
What is r&d to revenue?
R&D spending as percentage of revenue.
FMCQF r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it, in percentage points.
| Period ending | R&D to Revenue | Change |
|---|---|---|
| 0.805% | −0.14 pts | |
| 0.949% | −0.24 pts | |
| 1.1924% | +0.01 pts | |
| 1.1786% | −0.08 pts | |
| 1.2543% | +0.17 pts | |
| 1.0863% | +0.13 pts | |
| 0.9613% | +0.15 pts | |
| 0.8098% | +0.07 pts | |
| 0.7366% | −0.17 pts | |
| 0.9045% | +0.07 pts | |
| 0.8364% | +0.07 pts | |
| 0.7706% | −0.09 pts | |
| 0.8611% | +0.05 pts | |
| 0.8089% | −0.06 pts | |
| 0.8662% | +0.07 pts | |
| 0.8009% | −0.03 pts | |
| 0.8341% | +0.08 pts | |
| 0.7561% | +0.07 pts | |
| 0.6844% | +0.08 pts | |
| 0.6035% | −0.15 pts | |
| 0.7525% | −0.07 pts | |
| 0.8247% | −0.07 pts | |
| 0.8989% | −0.03 pts | |
| 0.933% | +0.20 pts | |
| 0.7347% | −0.03 pts | |
| 0.7601% | −0.09 pts | |
| 0.8459% | −0.04 pts | |
| 0.89% | +0.89 pts | |
| 0% | — |
Frequently asked questions: FMCQF r&d to revenue
What is Fresenius Medical Care AG & Co. KGaA (FMCQF)'s current r&d to revenue?
Fresenius Medical Care AG & Co. KGaA (FMCQF)'s latest reported r&d to revenue (Fiscal year) is 0.80% as of Dec 31, 2025. R&D spending as percentage of revenue.
How much historical r&d to revenue data is available for FMCQF?
Stock Alarm Pro provides 29 dated annual fiscal periods observations for Fresenius Medical Care AG & Co. KGaA (FMCQF)'s r&d to revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare FMCQF's r&d to revenue to peers or set an alert?
You can open FMCQF's r&d to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on FMCQF delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance